Sepehr Sarshar was accused on Tuesday of misappropriating material nonpublic information from San Diego-based Auspex in early 2015 related to Teva’s expected tender offer, and passing tips to his girlfriend, two other friends and a close relative.
The office of acting U.S. Attorney Audrey Strauss in Manhattan said the resulting trading in Nasdaq-listed Auspex generated more than $700,000 of illegal profit.
‘Enforcement 40’ for 2020
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn